Jiuyo Capital - 久友资本

Jiuyo Capital is a venture capital firm specializing in early, middle stage, angel to pre-IPO investments. It primarily invests in hard and core technology, photoelectric chip, , information technology, robot, high-end equipment, aerospace, original innovation, life technology, original drug, precision medicine, biomedicine, high-end medical equipment. For biotechnology, the firm prefers to invest in innovative drugs, precision medicine, and innovative medical devices. For technology innovation, it typically invests in 5G technology, semiconductor core devices, Internet of Things, artificial intelligence, new materials, and intelligent manufacturing. For innovative drugs, it seeks to invest in small molecules, proteins, nucleic acids, and cell therapy, and the main indications are anti-tumor, metabolism, liver disease, and pain. Jiuyo Capital was founded in 2015 and is based in Beijing, China.